Home › Funds › Parametrica Management Ltd › FATE
Parametrica Management Ltd position in FATE
FATE THERAPEUTICS INC · Health Care
Parametrica Management Ltd reported holding 18,472 shares of FATE (FATE THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$44K, representing 0.04% of its reported portfolio and ranking #26 among its reported holdings. Parametrica Management Ltd has disclosed FATE holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Parametrica Management Ltd's FATE position evolved
Parametrica Management Ltd first disclosed a stake in FATE in Q3 2023 at 18,472 shares (US$39K). The position peaked in Q1 2024 at 18,472 shares, worth US$136K. Across 13 filings, Parametrica Management Ltd held the position steady without any share-count change. The most recent filing (Q3 2026) shows 18,472 shares valued at US$44K.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 18.47K | $39.16K | New |
| Q4 2023 | 18.47K | $69.08K | Hold |
| Q1 2024 | 18.47K | $135.58K | Hold |
| Q2 2024 | 18.47K | $60.59K | Hold |
| Q3 2024 | 18.47K | $64.65K | Hold |
| Q4 2024 | 18.47K | $30.48K | Hold |
| Q1 2025 | 18.47K | $14.60K | Hold |
| Q2 2025 | 18.47K | $20.69K | Hold |
| Q3 2025 | 18.47K | $23.27K | Hold |
| Q4 2025 | 18.47K | $18.15K | Hold |
| Q1 2026 | 18.47K | $22.17K | Hold |
| Q2 2026 | 18.47K | $49.87K | Hold |
| Q3 2026 | 18.47K | $43.78K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About FATE and 13F data
FATE (FATE THERAPEUTICS INC) is a Health Care company. 19 other funds we track also report a position in FATE — the largest reported positions include Redmile Group, LLC (US$34.8M), JOHNSON & JOHNSON (US$8.0M), Bruce & Co., Inc. (US$2.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding FATE
- Redmile Group, LLC 12.87M sh · $34.76M · Q2 2026
- JOHNSON & JOHNSON 3.38M sh · $8.01M · Q3 2026
- Bruce & Co., Inc. 989.19K sh · $2.67M · Q2 2026
More on Parametrica Management Ltd
FAQ
How long has Parametrica Management Ltd held FATE?
Parametrica Management Ltd has disclosed FATE holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Parametrica Management Ltd's current position in FATE?
As of Q3 2026, Parametrica Management Ltd holds 18.47K shares of FATE (FATE THERAPEUTICS INC), valued at $43.78K, representing 0.04% of its reported portfolio and ranking #26.
Has Parametrica Management Ltd been buying or selling FATE?
In the latest 13F filing (Q3 2026), Parametrica Management Ltd held unchanged its position in FATE. The position peaked in Q1 2024 at 18.47K shares.
Which other funds hold FATE?
Other major institutional holders of FATE include Redmile Group, LLC, JOHNSON & JOHNSON, Bruce & Co., Inc., among 19 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.